DANIEL SAPEIKA: Open Payments
NPI 1043463110 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,493 in 17 payments from 8 companies in 2025. Trend: 2023 $1,005 · 2024 $3,001 · 2025 $1,493
Food & beverage: $1,493
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $509 |
| Medtronic, Inc. | 2 | $429 |
| Boston Scientific Corporation | 2 | $167 |
| Globus Medical, Inc. | 4 | $162 |
| SPR Therapeutics, Inc | 2 | $138 |
| Curonix LLC | 1 | $44 |
| Stryker Corporation | 1 | $25 |
| Saluda Medical Americas, Inc. | 1 | $20 |
Products named: PROCLAIM, INTELLIS ADAPTIVESTIM, Senza, WaveWriter Alpha Prime 16, INCEPTIV, SPRINT PNS System, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, SPINEJACK.
Industry payments across MI — which companies pay providers there.
